Merck nears US$10 billion deal for London-based lung therapy firm Verona, FT reports
Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing ...
Merck is nearing a US$10 billion deal to buy lung diseases focussed Verona Pharma, as the US drugmaker is eyeing ...
The Japanese commercial automaker and Taiwanese chipmaker are looking to create a new company to oversee the buses, according to ...
Struggling chipmaker Wolfspeed will be taken over by creditors including Apollo Global Management under a proposal that would put it ...
Global iron ore trade is facing a pivotal shift as Simandou, a massive iron ore mine in Guinea being developed ...
Global iron ore trade is facing a pivotal shift as Simandou, a massive iron ore mine in Guinea being developed ...
Samsung Electronics is nearing a wide-ranging deal to invest in Perplexity AI and put search technology from the artificial intelligence ...
Wall Street’s main indexes opened sharply lower on Monday (Apr 7), with the S&P 500 on track to confirm bear ...
OVER the five trading sessions from Feb 21 to Feb 27, institutions were net sellers of Singapore stocks, leading to ...
DELL Technologies is in advanced stages of securing a deal worth more than US$5 billion to provide Elon Musk’s xAI ...
KKR is more than halfway to a US$20 billion money-raising goal for its North America buyout fund, a sign of ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.